Feldan Therapeutics
Operator of a peptide-based intracellular delivery platform designed to enable access to therapeutic targets within cells for the treatment of serious diseases. The company offers a proprietary shuttl...
Valuation
$40.3M
Market implied
Share Price
N/A
Total Raised
$39.2M
Last Round
N/A